Keloid banding using suture ligature: A novel technique and review of literature

Laryngoscope

Volumn 118, Issue 11, 2008, Pages 1960-1965

  Parikh, Dhavan A ^a   Ridgway, James M ^a   Ge, Norman N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Banding; Keloid scar; Suture ligature

Indexed keywords

ANTIBIOTIC AGENT; HYDROGEN PEROXIDE; TRIAMCINOLONE;

ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; COMPRESSION BANDAGE; DIABETIC PATIENT; FOLLOW UP; HUMAN; KELOID; MALE; NECK; PRIORITY JOURNAL; SINGLE DRUG DOSE; SKIN INFECTION; SURGICAL TECHNIQUE; SUTURING METHOD; WOUND CARE; WOUND HEALING; HEAD INJURY; INJURY SCALE; INSTRUMENTATION; LIGATION; METHODOLOGY; MIDDLE AGED; NECK INJURY; PATHOLOGY;

CRANIOCEREBRAL TRAUMA; FOLLOW-UP STUDIES; HUMANS; KELOID; LIGATION; MALE; MIDDLE AGED; NECK INJURIES; SUTURE TECHNIQUES; TRAUMA SEVERITY INDICES;

EID: 56149102709     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181817b61     Document Type: Article

References (58)

1. Horn DB. Wound healing in relation to scarring. Facial Plast Surg North Am 1998;6:111-123.
2. Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981;4:461-470.
3. Horn D. Treating the elusive keloid. Arch Otolaryngol Head Neck Surg 2001;127:1140-1143.
4. Al-Attar A, Mess S, Thomassen JM, Kauffman LC, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006;117:286-300.
5. Howes EL, Sooy JW, Harvey SC. Healing of wounds as determined by their tensile strength. JAMA 1929;92:42-45.
6. Amadeu T, Braune A, Mandarim-de-Lacerda C, Porto LC, Desmouliere A, Costa A. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Pathol Res Pract 2003;199:469-473.
7. Peacock EE Jr, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J 1970;63:755-760.
8. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002;110:560-571.
9. Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsten BR. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7pll. J Invest Dermatol 2004;122:1126-1132.
10. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990;43:70-77.
11. Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994;12:27-37.
12. Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm Venereol 1995;75:102-104.
13. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 1989;84:827-837.
14. Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145:105-113.
15. Blackburn WR, Cosman B. Histological basis of keloid and hypertrophic scar differentiation: clinicopathologic correlation. Arch Pathol 1996;82:65-71.
16. Amadeu TP, Braune AS, Porto LC, Desmouliere A, Costa AM. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen 2004;12:169-174.
17. Atiyeh BS, Costagliola M, Hayek SN. Keloid or hypertrophic scar the controversy: review of the literature. Ann Plast Surg 2005;54:676-680.
18. Russell SB, Trupin KM, Rodriguez-Eaton S, Russell JD, Trupin JS. Reduced growth-factor requirement of keloid derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 1988;85:587-591.
19. Haisa M, Okochi H, Grotendorst G. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994;103:560-563.
20. Chodon T, Sugihara T, Igawa HH, Funayama E, Furukawa H. Keloid-derived fibroblasts are refractory to Fasmediated apoptosis and neutralization of autocrine transforming growth factor-betal can abrogate this resistance. Am J Pathol 2000;157:1661-1669.
21. De Felice B, Ciarmiello LF, Mondola P, et al. Differential p63 and p53 expression in human keloid fibroblasts and hypertrophic scar fibroblasts. DNA Cell Biol 2007;26:541-547.
22. Crook T, Nicholls JM, Brooks L, O'Nions J, Allday MJ. High level expression in DN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPQ? Oncogene 2000;19:3439-3444.
23. Sussman MD. Effect of increased tissue traction upon tensile strength of cutaneous incisions in rats. Proc Soc Exp Biol Med 1966;123:38-41.
24. Curtis AS, Seehar GM. The control of cell division by tension or diffusion. Nature 1978;274:52-53.
25. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. Soc Invest Derm 2003;121:1326-1331.
26. Marneros AG, Norris JEC, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001;137:1429-1434.
27. Kelly AP. Keloids. Dermatol Clin 1988;6:413-424.
28. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomas on A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 1992;140:1375-1388.
29. Hollander A. Intralesional injections of triamcinolone acetonide: a therapy for dermatoses. Antibiot Med Clin Ther 1961;8:78-83.
30. McCoy BJ, Diegelmann RF, Cohen IK. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 1980;163:216-222.
31. Darzi M, Chowdi N, Kaul S, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992;45:374-379.
32. Brody GS. Keloids and hypertrophic scars. Plast Reconstr Surg 1990;86:804.
33. Cosman B, Wolff M. Correlation of keloid recurrence with completeness of local excision. A negative report. Plast Reconstr Surg 1972;50:163-166.
34. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg 1996;22:126-130.
35. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001;107:87-96.
36. Murray J, Anscher M, Mayberry A, Levin L. Surgical excision, radiotherapy, and intralesional steroids. In: Harahap M, ed. Surgical Techniques for Cutaneous Scar Revision. New York, NY: Marcel Dekker; 2000:435-446.
37. Sclafani AP, Gordon L, Chadha M, Romo T. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg 1996;22:569-574.
38. Akita S, Akino K, Yakabe A, et al. Combined surgical excision and radiation therapy for keloid treatment. J Craniofacial Surgery 2007;18:1164-1169.
39. Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg 2007;33:1291-1303.
40. Katz BE. Silicone gel sheeting in scar therapy. Cutis 1995;56:65-67.
41. Nason KH. Keloids and their treatment. N Engl J Med 1942;226:883.
42. Kischer CW, Shetlar MR, Shetlar CL. Alteration of hypertrophic scars induced by mechanical pressure. Arch Dermatol 1975;111:60-64.
43. Davies DM. Plastic and reconstructive surgery. Scars, hypertrophic scars, and keloids. Br Med J (Clin Res Ed) 1985;290:1056-1058.
44. Lindsey WH, Davis PT. Facial keloids: a 15-year experience. Arch Otolaryngol Head Neck Surg 1997;123:397-400.
45. Norris JE. Superficial x-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast ReconstrSurg 1995;95:1051-1055.
46. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:224-232.
47. Larrabee WF Jr, East CA, Jaffe HS, Stephenson C, Peterson KE. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990;116:1159-1162.
48. D'Andre a F, Brongo S, Ferraro G, Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology 2002;204:60-62.
49. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg 2003;111:1841-1852.
50. Topol BM, Lewis VL Jr, Benveniste K. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar, and keloid. Plast Reconstr Surg 1981;68:227-232.
51. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006;18:396-402.
52. Ahn ST, Monafo WW, Mustoe TA Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991;126:499-504.
53. Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg 2001;7:641-644.
54. Stashower ME. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg 2006;32:380-386.
55. Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg 2005;31 (11 Pt 1) :1394-1398.
56. Malhotra AK, Gupta S, Khaitan BK, Sharma VK. Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids. Dermatology 2007;215:63-65.
57. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 1997;77:701-730.
58. Jacob SE, Berman B, Nassiri M, Vincek V. Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis. Br J Dermatol 2003;149 (suppl 66) :62-65.